# ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors

> **NCT06556108** · PHASE1,PHASE2 · COMPLETED · sponsor: **Xinqiao Hospital of Chongqing** · enrollment: 5 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **BIOLOGICAL:** ALPP CAR-T cells
- **DRUG:** Fludarabine
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT06556108
- **Lead sponsor:** Xinqiao Hospital of Chongqing
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2025-01-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06556108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06556108, "ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06556108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*